Idea to Product: The Process

Front Cover
Nancy J. Alexander, Anne C. Wentz
Springer Science & Business Media, Sep 27, 1996 - Medical - 200 pages
The young investigator with an idea has to negotiate many institutional, federal, and industrial challenges in order to get a product to market. Nowhere is described the steps in the development of new drugs, diagnos tics, or devices; the person with an idea has nowhere to turn for information and details. The young investigator may understand the elements of basic and clinical research, but ordinarily has no insight into novel ways of finding research funding or how to explore to find the funding opportunities that are available. The young investigator has little knowledge of the mecha nisms to bring an idea through the developmental phases to the market. There are other players in this complex endeavor with whom he or she has no contact, including those from industry, the Food and Drug Administration, and the legal community. Exposure to the philosophy of product develop ment and to procedural information would be useful to the scientific com munity, as would contact with those who have successfully taken an idea to a finished product. A first attempt to do this was the symposium on Idea to Product: The Process, sponsored by Serono Symposia USA and held No vember 17 to 20, 1994, in Washington, D.C. This book comprises the pro ceedings of that meeting. The editors are indebted to the many contributors to this volume, and we are especially grateful to Serono Symposia USA and to Leslie Nies and her staff for their expertise in organizing the symposium.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Selected pages

Contents

The Preclinical Research Process
1
The Commercial Development Process
3
Whats Involved in Clinical Research?
7
Product Development Partnership Role of Academia and the NIH
15
Identifying Funding Opportunities at the NIH A Grants Perspective
19
Identifying Funding Opportunities at the NIH A Contract Perspective
23
Role of the Institution in Furthering the Young Investigator
31
Role of Toxicology in Drug Discovery and Development
45
Patenting and Licensing An Overview of the Processes
95
Pharmaceutical Clinical Development
101
FDA Recommendations for Drug Safety Testing
113
Decision Strategies in Assessment of Reproductive and Developmental Toxicology A Paradigm for Safety Evaluation
117
What Is Involved in a New Drug Application?
131
Institutional Review Boards and Informed Consent
139
Postmarketing Surveillance A Brief Synopsis of Its History and Current Direction
145
I Had an Idea and I Made it Work Heres How
157

Pharmacokinetics Study
47
Formulation of Dosage Forms
49
Polymeric Drug Delivery Systems
51
What Is a Drug a Device a Biological?
67
Understanding the Organization and Function of the FDA
73
How to Apply for an IND
79
What Is a 510k and a PMA?
85
Working with Companies to Market Your Discoveries
163
Developing Information for HealthCare Decision Makers
165
Getting a Medical Products Business Started
167
From StartUp to Initial Public Offering
177
Author Index
187
Subject Index
189
Copyright

Other editions - View all

Common terms and phrases

Popular passages

Page xii - University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick; President, The Robert Wood Johnson Foundation, Princeton.

Bibliographic information